Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
A dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and weight management, demonstrating up to 22.5% weight loss in trials.
Lowest Price
$49.99
Highest Price
$3090.00
Average Price
$580.18
Potential Savings
71%
across 11 options
Prices are estimates and may vary. For research use only. We may earn a commission on purchases through affiliate links. Not medical advice.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Every vendor on this page is verified for endotoxin testing — not just HPLC purity.
The SURPASS trials (1-5) demonstrated superior HbA1c reduction versus semaglutide 1mg, insulin degludec, and insulin glargine in type 2 diabetes. SURMOUNT-1 (Jastreboff et al., NEJM 2022) showed weight reductions of 15%, 19.5%, and 20.9% at 5mg, 10mg, and 15mg doses respectively versus 3.1% with placebo. SURMOUNT-2 showed 14.7% weight loss in patients with type 2 diabetes. SURMOUNT-3 demonstrated 26.6% weight loss when combined with intensive lifestyle intervention. Research into heart failure with preserved ejection fraction (HFpEF), obstructive sleep apnea, and MASH is ongoing.
This platform provides informational tools only, not medical advice.
Prices verified as of April 2026. Actual prices may vary. For research use only.
Disclosed Labs